|
Title
|
Publication Date
|
Price
|
Relevance
|
|
Abbott Laboratories-Therapeutic Competitors
|
Mar 2011 |
£220 |
100% |
|
Abbott Laboratories-Detailed Product Pipeline
|
Mar 2011 |
£475 |
99% |
|
Abbott Laboratories: Corporate Analysis
|
May 2008 |
£255 |
99% |
OOO Abbott Laboratories Company Profile
Top 20 Pharmaceutical Companies in Russia:
|
Dec 2009 |
£200 |
99% |
|
Abbott Laboratories: PharmaVitae Profile
|
May 2011 |
£3,605 |
99% |
|
Pharma Company Profiles - Abbott Laboratories
|
Oct 2008 |
£255 |
99% |
|
Abbott Laboratories Strategic Analysis Profile
|
Dec 2007 |
£500 |
99% |
|
Abbott Laboratories - SWOT Framework Analysis
|
Jan 2011 |
£63 |
99% |
Abbott Laboratories - Product Pipeline Review
Q4 2010
|
Nov 2010 |
£315 |
98% |
|
Abbott Laboratories-IT Sales Opportunities-2009
|
Apr 2009 |
£355 |
98% |
|
Abbott Laboratories: Pipeline, Products, Performance, Potential
|
Aug 2009 |
£595 |
98% |
|
Abbott Laboratories-Deals & Alliances Report
|
Mar 2011 |
£380 |
98% |
Abbott Laboratories Likely to Reap Benefits from Strategic Split
Deal Analysis from GlobalData
|
Nov 2011 |
£315 |
98% |
Abbott Laboratories
Market Share Analysis
|
Jun 2010 |
£630 |
96% |
China Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
Aug 2008 |
£1,895 |
90% |
United States Diabetes Care Devices Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Glucose Monitoring and Insulin Delivery Devices, Equipment and Supplies
|
Apr 2008 |
£1,895 |
89% |
United States Patient Monitoring Devices Medical equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Multiparameter, Wireless, Ambulatory and Remote Monitoring Equipment, Devices, Appliances and Supplies
|
Apr 2008 |
£1,895 |
89% |
|
Abbott Medical Device Company Intelligence Report
|
Oct 2011 |
£595 |
89% |
United States in Vitro Diagnostics Industry Report
Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits
|
May 2008 |
£1,895 |
88% |
|
Brazil Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1,895 |
88% |
|
North America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
|
Jan 2009 |
£1,895 |
88% |
|
South Africa Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1,895 |
88% |
|
Brazil Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
Oct 2008 |
£1,895 |
88% |
|
Mexico Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
Nov 2008 |
£1,895 |
88% |
|
Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
Dec 2008 |
£1,895 |
88% |
|
Genetic Testing
|
Jan 2011 |
£2,845 |
88% |
|
Molecular Diagnostics
|
Oct 2010 |
£2,845 |
87% |
Who's Doing What in Molecular Diagnostics?
Kalorama / Emmes Survey of US Laboratories
|
Feb 2009 |
£3,160 |
87% |
|
OTC Pharmaceuticals in Brazil
|
Nov 2010 |
£160 |
87% |
|
Japan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
Oct 2008 |
£1,895 |
87% |
